NO20042084L - 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse - Google Patents

6-hydroksyisoflavoner, derivater og legemidler som omfatter disse

Info

Publication number: NO20042084L
Authority: NO; Norway
Prior art keywords: hydroxyisoflavones; drugs; derivatives
Prior art date: 2001-10-25

Application number

NO20042084A

Other languages

English (en)

Inventor

Andrew Heaton

Graham Edmund Kelly

Original Assignee

Novogen Res Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-25

Filing date

2004-05-21

Publication date

2004-05-21

2004-05-21 Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd

2004-05-21 Publication of NO20042084L publication Critical patent/NO20042084L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Immunology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)

NO20042084A 2001-10-25 2004-05-21 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse NO20042084L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPR8464A AUPR846401A0 (en)	2001-10-25	2001-10-25	6-Hydroxy isoflavones, derivatives and medicaments involving same
PCT/AU2002/001442 WO2003035635A1 (en)	2001-10-25	2002-10-25	6-hydroxy isoflavones, derivatives and medicaments involving same

Publications (1)

Publication Number	Publication Date
NO20042084L true NO20042084L (no)	2004-05-21

Family

ID=3832286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042084A NO20042084L (no)	2001-10-25	2004-05-21	6-hydroksyisoflavoner, derivater og legemidler som omfatter disse

Country Status (11)

Country	Link
US (1)	US20050049424A1 (no)
EP (1)	EP1448542A4 (no)
JP (1)	JP2005510503A (no)
CN (1)	CN1575289A (no)
AU (1)	AUPR846401A0 (no)
CA (1)	CA2464593A1 (no)
HU (1)	HUP0401648A3 (no)
IL (1)	IL161517A0 (no)
MX (1)	MXPA04003874A (no)
NO (1)	NO20042084L (no)
WO (1)	WO2003035635A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP260798A0 (en) *	1998-03-26	1998-04-23	Novogen Research Pty Ltd	Treatment of medical related conditions with isoflavone containing extracts of clover
US20040072765A1 (en) *	1999-04-28	2004-04-15	Novogen Research Pty Ltd.	Cardiovascular and bone treatment using isoflavones
AUPQ520300A0 (en) *	2000-01-21	2000-02-17	Novogen Research Pty Ltd	Food product and process
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
MX2007003216A (es)	2004-09-21	2008-03-10	Novogen Res Pty Ltd	Derivados y medicamentos sustituidos del cromano y su uso en terapias.
WO2006099193A2 (en) *	2005-03-11	2006-09-21	The Regents Of The University Of Michigan	Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
NZ561574A (en) *	2005-03-24	2010-03-26	Novogen Res Pty Ltd	Anti-inflammatory modalities for use against pain, oedema, and erythema (benzotetrahydropyrans, benzopyran derivatives, isoflavonoid derivatives)
TWI366565B (en)	2007-06-06	2012-06-21	Otsuka Pharma Co Ltd	Quinolone compound and pharmaceutical composition
WO2009049214A2 (en) *	2007-10-12	2009-04-16	Northwestern University	Inhibition and treatment of prostate cancer metastasis
JP5564499B2 (ja)	2008-07-31	2014-07-30	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	前立腺癌の進行を予防または減退させるのに有効な組成物
WO2010042933A2 (en) *	2008-10-10	2010-04-15	Northwestern University	Inhibition and treatment of prostate cancer metastasis
TWI492943B (zh)	2008-12-05	2015-07-21	大塚製藥股份有限公司	喹啉酮化合物及藥學組成物（二）
BR112012008238A2 (pt) *	2009-10-09	2017-06-06	Nestec Sa	métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais.
WO2011156889A1 (en) *	2010-06-14	2011-12-22	Trt Pharma Inc.	Novel modulators of nrf2 and uses thereof
US9708283B2 (en)	2010-11-01	2017-07-18	Mei Pharma, Inc.	Isoflavonoid compositions and methods for the treatment of cancer
WO2012066330A1 (en)	2010-11-17	2012-05-24	Heptares Therapeutics Limited	Compounds useful as a2a receptor inhibitors
WO2016126618A1 (en)	2015-02-02	2016-08-11	Mei Pharma, Inc.	Combination therapies
CN104829580B (zh) *	2015-04-11	2017-11-24	云南中烟工业有限责任公司	烟草所含的异黄酮类化合物及其制备方法和应用
US9718799B2 (en) *	2015-05-11	2017-08-01	University Of Kentucky Research Foundation	3-aryl-4H-chromene-4-ones as antineoplastic agents for the treatment of cancer
JP6099024B2 (ja) *	2015-05-18	2017-03-22	株式会社東洋新薬	ホスホジエステラーゼ３阻害剤
EP3439644B1 (en)	2016-04-06	2022-01-12	Noxopharm Limited	Isoflavonoid composition with improved pharmacokinetics
EP3439642A4 (en)	2016-04-06	2019-11-13	Noxopharm Limited	IMPROVEMENTS IN RADIATION THERAPY
CN107441079B (zh) *	2017-08-22	2021-03-26	四川省中医药科学院	一种治疗心脑血管疾病的药物及其制备方法和用途
CA3098428A1 (en)	2018-04-18	2019-10-24	Constellation Pharmaceuticals, Inc.	Modulators of methyl modifying enzymes, compositions and uses thereof
CA3100977A1 (en)	2018-05-21	2019-11-28	Constellation Pharmaceuticals, Inc.	Modulators of methyl modifying enzymes, compositions and uses thereof
WO2020045856A1 (ko) *	2018-08-31	2020-03-05	서울대학교 산학협력단	신규한 HIF-1α 억제제, 이의 제조방법 및 이를 유효성분으로 함유하는 신생혈관 관련 안질환의 예방 또는 치료용 약학적 조성물
KR102527205B1 (ko) *	2018-08-31	2023-05-03	서울대학교산학협력단	신규한 HIF-1α 억제제, 이의 제조방법 및 이를 유효성분으로 함유하는 신생혈관 관련 안질환의 예방 또는 치료용 약학적 조성물
WO2020051644A1 (en) *	2018-09-13	2020-03-19	Norbio No. 2 Pty Ltd	Treatment of peripheral nervous tissue inflammation
CN109925308A (zh) *	2018-12-29	2019-06-25	广东宏盈科技有限公司	异黄酮在制备治疗眼底黄斑病变的药物中的应用
CN110590738B (zh) *	2019-08-27	2022-03-01	温州大学	一种3,6-二甲基-1-仲胺基-7-氰基-8-羟基异喹啉类化合物的合成方法
EP4125870A1 (en)	2020-03-30	2023-02-08	Noxopharm Limited	Methods for the treatment of inflammation associated with infection
WO2021195698A1 (en) *	2020-03-30	2021-10-07	Noxopharm Limited	Methods for the treatment of inflammation associated with infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4264509A (en) *	1977-06-08	1981-04-28	Z-L Limited Partnership	Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
GB8626344D0 (en) *	1986-11-04	1986-12-03	Zyma Sa	Bicyclic compounds
DE69333624T2 (de) *	1992-05-19	2005-09-15	Novogen Research Pty. Ltd., North Ryde	Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
AUPO203996A0 (en) *	1996-08-30	1996-09-26	Novogen Research Pty Ltd	Therapeutic uses
GB9621757D0 (en) *	1996-10-18	1996-12-11	Ciba Geigy Ag	Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5733926A (en) *	1996-12-13	1998-03-31	Gorbach; Sherwood L.	Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
US6146668A (en) *	1997-04-28	2000-11-14	Novogen, Inc.	Preparation of isoflavones from legumes
CA2287965C (en) *	1997-05-01	2009-10-20	Graham Edmund Kelly	Treatment or prevention of menopausal symptoms and osteoporosis
AU3456499A (en) *	1998-03-30	1999-10-18	University Of Mississippi, The	Isoflavones for treating giardiasis and malaria
AUPQ008299A0 (en) *	1999-04-30	1999-05-27	G.J. Consultants Pty Ltd	Isoflavone metabolites
FI20001593A (fi) *	2000-07-03	2002-01-04	Orion Yhtymo Oyj	Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
EP1368024A4 (en) *	2001-03-16	2009-03-18	Novogen Res Pty Ltd	TREATMENT OF RESTENOSIS

2001
- 2001-10-25 AU AUPR8464A patent/AUPR846401A0/en not_active Abandoned
2002
- 2002-10-25 IL IL16151702A patent/IL161517A0/xx unknown
- 2002-10-25 EP EP02771876A patent/EP1448542A4/en not_active Withdrawn
- 2002-10-25 CA CA002464593A patent/CA2464593A1/en not_active Abandoned
- 2002-10-25 WO PCT/AU2002/001442 patent/WO2003035635A1/en not_active Application Discontinuation
- 2002-10-25 MX MXPA04003874A patent/MXPA04003874A/es unknown
- 2002-10-25 CN CNA028211154A patent/CN1575289A/zh active Pending
- 2002-10-25 JP JP2003538151A patent/JP2005510503A/ja active Pending
- 2002-10-25 HU HU0401648A patent/HUP0401648A3/hu unknown
- 2002-10-25 US US10/493,390 patent/US20050049424A1/en not_active Abandoned
2004
- 2004-05-21 NO NO20042084A patent/NO20042084L/no unknown

Also Published As

Publication number	Publication date
US20050049424A1 (en)	2005-03-03
AUPR846401A0 (en)	2001-11-15
JP2005510503A (ja)	2005-04-21
IL161517A0 (en)	2004-09-27
EP1448542A4 (en)	2005-11-16
HUP0401648A1 (hu)	2004-11-29
WO2003035635A1 (en)	2003-05-01
MXPA04003874A (es)	2004-07-16
CA2464593A1 (en)	2003-05-01
CN1575289A (zh)	2005-02-02
HUP0401648A3 (en)	2007-05-29
EP1448542A1 (en)	2004-08-25

Publication	Publication Date	Title
NO20042084L (no)	2004-05-21	6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
NO20035220D0 (no)	2003-11-24	Karboksamidsubstituerte fenylureaderivater og fremgangsmåter for fremstilling av disse som legemidler
NO20035298D0 (no)	2003-11-28	CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20042906L (no)	2004-07-09	Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
NO20052855D0 (no)	2005-06-13	Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
DK1534277T3 (da)	2012-01-09	Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
DK1572707T3 (da)	2006-08-14	Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
DK1401806T3 (da)	2006-11-27	Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
NO20033726L (no)	2003-08-21	Xantin-derivater, fremstilling og anvendelse derav som et medikament
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1373191T3 (da)	2013-08-26	Acylerede indanylaminer og deres anvendelse som lægemidler
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
NO20025357D0 (no)	2002-11-08	Antranylamider og deres anvendelse som legemidler
DK1445252T3 (da)	2006-06-19	Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
DK1095025T3 (da)	2003-04-07	Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20005146D0 (no)	2000-10-13	Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO20042907L (no)	2004-07-09	Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
NO20040214L (no)	2004-03-18	Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav
NO20023144L (no)	2002-12-30	Et kompleks som omfatter OCIF og polysakkarid
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20013816L (no)	2001-08-03	Benzamidderivater og legemidler som inneholder disse
DK1263719T3 (da)	2009-11-16	N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.